Global Inferior vena cava (IVC) filter Market, By Product Type (Retrievable Inferior Vena Cava filters, Permanent Inferior Vena Cava Filters), Material (Non-Ferromagnetic Material, Ferromagnetic Materials), Application (Treatment of Venous Thromboembolism, Prevention of Pulmonary Embolism), End User (Hospitals, Ambulatory Surgical Centers, Emergency Care Centers) - Industry Trends and Forecast to 2030.
Inferior Vena Cava (IVC) Filter Market Analysis and Size
The inferior vena cava (IVC) refers to the most prominent vein in the body responsible for carrying de-oxygenated blood to the heart’s right atrium and then to the lungs. It is considered the main vessel that returns blood from the lower half of the body to the heart. The IVC filter is defined as a small cone-shaped device that is generally implanted in the inferior vena to capture blood clots and prevent them from reaching the lungs.
Data Bridge Market Research analyses that the Inferior vena cava (IVC) filter Market which was USD 758.23 million in 2022, would rocket up to USD 1,558.56 million by 2030, and is expected to undergo a CAGR of 8.79% during the forecast period. “Hospitals” dominates the end users segment of the Inferior vena cava (IVC) filter market owing to the availability of well qualified physicians and operating staff. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
Inferior Vena Cava (IVC) Filter Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Retrievable Inferior Vena Cava filters, Permanent Inferior Vena Cava Filters), Material (Non-Ferromagnetic Material, Ferromagnetic Materials), Application (Treatment of Venous Thromboembolism, Prevention of pulmonary embolism), End User (Hospitals, Ambulatory Surgical Centers, Emergency Care Centers)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Boston Scientific Corporation (U.S.), Abbott (U.S.), Cardinal Health (U.S.), Cook (U.S.), Terumo Europe NV (Belgium), Stryker (U.S.), B. Braun Melsungen AG (Germany), Samsung Healthcare (South Korea), Canon Medical Systems (Japan), Siemens Healthcare Private Limited (Germany), Shimadzu Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Hologic, Inc. (U.S.), General Electric Company (U.S.), Esaote SpA (Italy)
|
|
Market Opportunities
|
|
Market Definition
Inferior vena cava (IVC) filters are implanted in the inferior vena cava, a large vein that carries deoxygenated blood from the lower body to the heart, with the aim of preventing pulmonary embolism (PE) by capturing and trapping blood clots or emboli that may travel from deep vein thrombosis (DVT) in the lower extremities. IVC filters are typically indicated for patients at risk of developing PE who are unable to tolerate or have contraindications to anticoagulant therapy.
Global Inferior Vena Cava (IVC) Filter Market Dynamics
Drivers
- Increasing Incidence of Venous Thromboembolism (VTE)
Venous thromboembolism, including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major driver for the IVC filters market. The rising incidence of VTE, attributed to factors such as sedentary lifestyles, obesity, and an aging population, creates a growing need for preventive measures like IVC filters.
- Advancements in IVC Filter Technologies
Minimally invasive procedures have gained significant popularity across various medical specialties. These procedures offer advantages such as reduced risk, shorter hospital stays, faster recovery times, and improved patient comfort. Inferior vena cava (IVC) filters play a crucial role in guiding and facilitating image-guided interventions, such as image-guided biopsies, ablations, and vascular interventions. The increasing adoption of minimally invasive procedures is driving the demand for Inferior vena cava (IVC) filters as healthcare facilities invest in advanced imaging technology to support these procedures and improve patient outcomes.
Opportunities
- Development of Advanced Filter Designs
The future of IVC filters lies in the development of advanced filter designs that offer improved efficacy, safety, and patient outcomes. Opportunities exist for companies to invest in research and development to create filters with enhanced capabilities, such as better clot-trapping efficiency, reduced risk of complications, and increased retrievability.
- Telemedicine and Remote Monitoring
With the growing adoption of telemedicine and remote monitoring technologies, there are opportunities to integrate IVC filter monitoring into these platforms. Remote monitoring of filter performance and patient follow-up can enhance patient care, improve compliance, and enable timely intervention if complications arise.
Restraints/Challenges
There are various obstacles that may hinder the expansion of the Inferior vena cava (IVC) filter market. These challenges include safety concerns and complications, retrieval challenges, availability of alternate treatment options etc. These factors can impede market growth and pose barriers for market players in the forecast period of 2023-2030
This Inferior vena cava (IVC) filter Market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Inferior vena cava (IVC) filter Market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Development
- In May 2022, Terumo India, a global leader in medical technology, announced a partnership agreement with Argon Medical. This expands Terumo India’s portfolio to include end to end solutions for interventional radiology, vascular surgery, interventional cardiology and clinical oncology.
Global Inferior Vena Cava (IVC) Filter Market Scope
The Inferior vena cava (IVC) filter Market is segmented ON the basis of product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Retrievable Inferior Vena Cava filters
- Permanent Inferior Vena Cava Filters
Material
- Non-Ferromagnetic Material
- Ferromagnetic Materials
Application
- Treatment of Venous Thromboembolism
- Prevention of Pulmonary Embolism
End Users
- Hospitals
- Ambulatory Surgical Centers
- Emergency Care Centers
Inferior vena cava (IVC) filter Market Regional Analysis/Insights
The Inferior vena cava (IVC) filter Market is analysed, and market size insights and trends are provided by country, product type, material, application and End Users as referenced above.
The countries covered in the Inferior vena cava (IVC) filter market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the inferior vena cava (IVC) filter market because of the prevalence of cardiovascular diseases and strokes within the region.
Asia-Pacific is estimated to witness the fastest growth during the forecast period of 2021-2028 due to the large patient pool and developing healthcare infrastructure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Inferior Vena Cava (IVC) Filter Market Share Analysis
The inferior vena cava (IVC) filter market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the inferior vena cava (IVC) filter market.
Some of the major players operating in the inferior vena cava (IVC) filter market are:
- Boston Scientific Corporation (U.S.)
- Abbott (U.S.)
- Cardinal Health (U.S.)
- Cook (U.S.)
- Terumo Europe NV (Belgium)
- Stryker (U.S.)
- B. Braun Melsungen AG (Germany)
- Samsung Healthcare (South Korea)
- Canon Medical Systems (Japan)
- Siemens Healthcare Private Limited (Germany)
- Shimadzu Corporation (Japan)
- Koninklijke Philips N.V. (Netherlands)
- Hologic, Inc. (U.S.)
- General Electric Company (U.S.)
- Esaote SpA (Italy)
SKU-